CPT Capital
VC Fund
London, United Kingdom
CPT Capital is an investment firm that invests in visionary founders. Their mission is to drive the food and materials technology revolution by replacing animals in the supply chain.
- Total investments:
- 63
- Last investment:
- Lead investor:
- 13%
Last updated:
For AI agents: llms.txt
Industries CPT Capital invests in
Stages CPT Capital invests in
Countries CPT Capital invests in
Round sizes
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Round size
- Seed
- $1.3M–$7M
- Series A
- $6M–$50M
- Series B
- $16M–$226M
Investment Focus
Industry
- Food and Beverage 27 (43%)
- Biotechnology 19 (30%)
- Food Processing 16 (25%)
- Manufacturing 8 (13%)
- Alternative Protein 6 (10%)
Stage
- Seed 20 (32%)
- Series A 17 (27%)
- Series B 10 (16%)
- Pre-Seed 4 (6%)
- Series C 3 (5%)
Country
- United States 14 (22%)
- Israel 11 (17%)
- United Kingdom 9 (14%)
- Germany 3 (5%)
- Hong Kong 2 (3%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Debbie Jones
Chief Financial Officer
|
Chief Financial Officer | Total investments: 0 | Find email | |
Harry Kalms
Senior Investment Associate
|
Senior Investment Associate | Total investments: 2 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| Asterix Foods is a biotechnology company designed to build protein production using plant-cell culture techniques. The company's platform is developing and growing bioactive proteins for food that are scalable, functional, and complex, enabling users with plant cell-cultured and animal-free proteins.It was founded in 2022 and is located inTel Aviv, Israel. | $4.2M / Seed / Oct 08, 2025 | ||
| Shiru leverages computational design to create enhanced proteins that feed the world sustainably. | $16M / Series B / Nov 12, 2024 | ||
| Xias Bio is a biotechnology startup specializing in the production of recombinant proteins, offering formulators advanced soluble, active ingredients with improved attributes such as enhanced gel and film formation, as well as antioxidant properties. The company creates non-immunogenic natural motifs to produce a better delivery platform offunctionalities for research, beauty, and healthcare. | $4.8M / Seed / May 01, 2024 | ||
| high expertise in the designing and testing of self-assembling peptides providing different benefits when culturing adherent cells in vitro. | $1.3M / Seed / Dec 04, 2023 | ||
| Based in Israel, Wanda Fish Technologies is a cell-cultured seafood startup that offers cultivated fish filets with similar nutrition, taste, and texture to real fish, using a GMO-free platform. Wanda Fish produces its cultivated fish by growing fat and muscle cells in a bioreactor using animal-free growth media. | $7M / Seed / Oct 09, 2023 | ||
Change Bio
|
Change Bio converts waste methane into proteins to make them more affordable and carbon-negative. | $315.3K / Pre-Seed / Aug 28, 2023 | |
| ENOUGH is a technology spin-out company from the University of Strathclyde established to develop and commercialise novel patented technology which transforms the production economics for the meat-free food product mycoprotein by integrating the production within existing bio-refinery operations producing bio-ethanol and animal feed (DDGS). Thisgives integrated fermentation production of Food, Fuel and Feed. | $43.9M / Series C / Aug 17, 2023 | ||
PoLoPo
|
PoLoPo is a biotech company that produces proteins on a large scale and according to specifications. PoLoPo develops a "superAA" plant by employing directed metabolic engineering techniques and fully utilizing plants' capacity as various metabolite and green protein factories. A significant amount of free amino acids can be producedby the superAA. The increased production of amino acids is then translated into an increase in the scale at which proteins are produced in plant organs. | $2.3M / Pre-Seed / Mar 20, 2023 | |
| Dextrous Robotics is a robotics company that develops AI-enabled warehouse robots. The company was founded in 2019 and is headquartered in Memphis, Tennessee. | Seed / Jan 01, 2023 | ||
| Liberation Labs believe that by innovating technology, It can free the world from the costs of industrialized agriculture and unlock a new era of accessible, healthy foods. The mission is to make precision fermentation by commercializing purpose-built manufacturing facilities for industrial biotech. | $20M / Seed / Dec 30, 2022 | ||
| See all 63 investments → | |||
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does CPT Capital invest in?
CPT Capital invests primarily in Food and Beverage, Biotechnology and Food Processing startups, most often at Seed and Series A stage. Most of the 63 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What round sizes does CPT Capital invest in?
CPT Capital typically joins rounds of $1.3M–$7M at Seed, $6M–$50M at Series A and $16M–$226M at Series B. These are whole funding-round sizes, not CPT Capital's own check, which is rarely disclosed: the 10th–90th percentile of the confirmed public funding rounds CPT Capital took part in.
How do I contact CPT Capital?
Public channels for CPT Capital include LinkedIn, X (Twitter) and the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at CPT Capital?
The team at CPT Capital includes Debbie Jones (Chief Financial Officer) and Harry Kalms (Senior Investment Associate). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Oct 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
